Replies to post #26572 on Revive Therapeutics Ltd (RVVTF)

[Cool888]

The safety of Sotrovimab is primarily based on an interim analysis from 868 patients (430 patients in the treatment arm and 438 in the placebo arm) through day 15.

Really FDA ? Another Big Pharma gets a "quick" EUA !!